Profil
Ji Li is the President & Director at AffaMed Therapeutics since 2021.
Prior to this, he worked as an Executive Licensing Director at Amgen, Inc. and as a Vice President-Business Development & Licensing at Merck Sharp & Dohme Corp.
From 2016 to 2018, he was the EVP & Global Head-Business Development at BeiGene Ltd.
Dr. Li holds a doctorate degree from Icahn School of Medicine at Mount Sinai and an undergraduate degree from Zhongshan Hospital Fudan University.
Postes actifs de Ji Li
| Sociétés | Poste | Début |
|---|---|---|
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | President | 30/03/2021 |
Anciens postes connus de Ji Li
| Sociétés | Poste | Fin |
|---|---|---|
| BEIGENE, LTD. | Directeur/Membre du Conseil | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Corporate Officer/Principal | - |
Formation de Ji Li
| Zhongshan Hospital Fudan University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Health Technology |
